09 Jun 2020 - First Graphene Limited (ASX:FGR) Non-Executive Chairman Warwick Grigor talks about graphene-enhanced products, the company's capital raising and its focus on the mining industry.
09 Jun 2020 - First Graphene Limited (ASX:FGR) Non-Executive Chairman Warwick Grigor talks about graphene-enhanced products, the company's capital raising and its focus on the mining industry.
03 Jun 2020 - Cyclopharm (ASX:CYC) Managing Director and CEO James McBrayer provides an update on US FDA progress with Technegas, approval in Russia and potential use of Technegas in the diagnosis and management of COVID-19.
01 Jun 2020 - NetLinkz Limited (ASX:NET) Executive Chairman & CEO James Tsiolis provides an update on the company's suite of networking solutions, the market opportunity and progress with partners.
01 Jun 2020 - OncoSil Medical Limited (ASX:OSL) Managing Director and CEO Daniel Kenny talks about the significance of the company's CE Marking approval for its lead product OncoSil, which helps treat pancreatic, liver and biliary duct cancer.
27 May 2020 - Hazer Group Limited (ASX:HZR) Managing Director and CEO Geoff Ward talks about the Hazer process for low emissions hydrogen gas and high purity graphite production from biogas, CAPEX approval to proceed with the company's commercial demonstration plant and offtake discussions.
26 May 2020 - LBT Innovations Limited (ASX:LBT) Managing Director and CEO Brent Barnes talks about progress with the company's microbiology culture plate reading device APAS Independence, which uses artificial intelligence to read and interpret plates, additional analysis module development, sales pipeline and strategy.
22 May 2020 - Novonix Limited (ASX:NVX) Managing Director Philip St Baker talks about the company's breakthrough dry particle microgranulation (DPMG) method for reducing waste in the manufacture of anode and cathode materials for lithium-ion batteries, restarting of operations in North America and outlook for 2H20.
13 May 2020 - Elixinol Global (ASX:EXL) CEO, Oliver Horn talks about its strategy to create a global nutraceuticals brand, with a focus on higher margin, consumer branded products, new management team, capital raising and FY 20 outlook.
06 May 2020 - Acorn Capital Investment Fund Ltd. (ASX: ACQ) Head of Research and Portfolio Manager for the Consumer Discretionary, Consumer Staples and Information Technology sectors, Robert Bruce talks about the listed investment company, the fund’s composition and outlook for the next 6 months and longer term.
